Dishman Carbogen Amcis Limited

BSE: DCAL540701ISIN INE385W01011

Healthcare
Pharmaceuticals
BSE 1000

Share price

₹154.50+3.60 (+2.39%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹305.50
52W low: ₹129.00
Off 52W high: -49.43%
1M return: +2.22%
3M return: -20.85%
6M return: -18.32%
1Y return: -48.01%
20D avg volume: 9,677
50 DMA: ₹160.22
200 DMA: ₹179.36

Key ratios Consolidated

Market cap: ₹2,422 Cr
Current price: ₹154.50
52W high / low: ₹305.50 / ₹129.00
Face value: ₹2.00
P/E: 158.63
P/B: 0.36
EPS (TTM): ₹1.03
Book value / share: ₹425.82
ROE: —
ROCE: 2.90%
Operating margin: —
Net margin: —
Debt / equity: 0.42
Net debt: ₹1,988 Cr
Interest cover: 1.60
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 184.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	677.64	851.40	719.80	652.65	708.05	716.34	682.34	789.04	523.78	654.71	651.09	586.59
	18.16	16.42	6.66	8.11	24.75	7.97	5.63	6.65	1.43	7.16	6.05	8.47
	695.80	867.82	726.46	660.76	732.80	724.31	687.97	795.69	525.21	661.87	657.14	595.06
	745.33	820.54	736.90	630.22	691.48	684.86	662.96	750.61	597.33	707.98	723.43	628.27
	144.66	120.36	127.79	34.10	205.60	154.15	161.58	216.09	61.14	158.72	202.53	137.87
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	389.10	406.21	355.88	332.94	351.90	324.94	332.08	319.73	316.82	320.77	309.20	283.06
	37.09	43.30	45.79	42.33	42.76	42.12	48.78	36.63	31.93	30.95	33.08	27.49
	90.68	88.79	84.42	84.13	81.35	79.09	71.97	72.09	70.59	85.00	80.37	75.04
	114.23	147.33	109.33	136.51	117.38	92.80	—	—	—	—	—	—
	-49.53	47.28	-10.44	30.54	41.32	39.45	25.01	45.08	-72.12	-46.11	-66.29	-33.21
	-1.69	-1.15	0.00	0.00	-2.65	-11.75	2.04	-2.96	-5.44	-3.09	0.00	-3.05
	-51.22	46.13	-10.44	30.54	38.67	27.70	27.05	42.12	-77.56	-49.20	-66.29	-36.26
	6.66	24.39	2.53	34.73	15.26	-15.39	22.42	9.03	0.01	20.72	6.66	4.64
	-57.88	21.74	-12.97	65.27	23.41	43.09	4.63	33.09	-77.57	-69.92	-59.63	-40.90
	-3.69	1.39	-0.83	4.16	1.49	2.75	0.30	2.11	-4.95	-4.46	-3.80	-2.61
Key metrics
	76.55	178.22	119.77	157.00	162.78	148.91	147.80	150.84	24.96	66.75	47.16	66.27
	11.30%	20.90%	16.60%	24.10%	23.00%	20.80%	21.70%	19.10%	4.80%	10.20%	7.20%	11.30%
	-8.50%	2.60%	-1.80%	10.00%	3.30%	6.00%	0.70%	4.20%	-14.80%	-10.70%	-9.20%	-7.00%
	—	0.90%	—	0.80%	—	0.90%	—	—	—	—	—	—
	-4.30%	18.90%	5.50%	-17.30%	35.20%	9.40%	4.80%	34.50%	—	—	—	—
	-347.20%	-49.50%	-380.10%	97.20%	130.20%	161.60%	107.80%	180.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	2,901	2,932	2,712	2,616	2,413	2,141
	49.35	55.94	21.68	28.21	27.77	43.42
	2,951	2,988	2,733	2,644	2,441	2,184
	2,933	2,879	2,696	2,760	2,447	2,174
	426.91	487.85	592.96	601.21	624.99	460.50
	0.00	0.00	0.00	—	—	—
	1,484	1,447	1,294	1,208	1,035	981.49
	168.51	174.18	159.46	119.97	85.69	56.81
	348.02	338.69	293.74	310.86	280.72	307.59
	507.40	510.55	447.34	—	—	—
	17.85	108.70	37.42	-116.12	-6.44	10.39
	-2.84	-3.80	-18.11	-6.14	-48.15	-14.64
	15.01	104.90	19.31	-122.26	-54.59	-4.25
	68.31	7.45	16.07	31.19	24.79	22.26
	16.16	97.45	3.24	-153.45	-29.80	18.01
	1.03	6.22	0.21	-9.79	-1.90	1.15
Key metrics
	531.54	617.77	472.51	308.57	311.82	360.15
	18.32%	21.10%	17.40%	11.80%	12.90%	16.80%
	0.56%	3.30%	0.10%	-5.90%	-1.20%	0.80%
	—	2.90%	2.20%	—	—	—
	0.20%	8.10%	3.70%	8.40%	12.70%	—
	-84.49%	2,907.70%	102.10%	-414.90%	-265.50%	—
	—	225.47	158.47	—	—	—
	—	5.04	115.81	—	—	—
	—	0.42	0.36	—	—	—
	—	1,988	1,743	—	—	—
	—	184.4	179.6	—	—	—
Balance sheet
	—	11,923	9,999	—	—	—
	—	2,842	2,200	—	—	—
	—	787.76	341.07	—	—	—
	—	672.91	665.14	—	—	—
	—	1,019	900.24	—	—	—
	—	116.02	83.62	—	—	—
	—	2,942	2,684	—	—	—
	—	211.18	230.68	—	—	—
	—	2,317	1,925	—	—	—
	—	2,775	2,084	—	—	—
	—	1,241	934.72	—	—	—
	—	1,535	1,149	—	—	—
	—	6,677	5,832	—	—	—
Cash flow
	—	491.45	375.23	—	—	—
	—	-245.34	-192.21	—	—	—
	—	200.58	-102.09	—	—	—
	—	265.98	216.76	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	57.08	68.72	39.68	60.30	62.86	106.10	97.04	93.29	103.41	111.26	86.82	59.72
	18.89	28.83	7.10	11.17	37.42	5.47	8.01	23.93	11.59	3.21	13.11	38.71
	75.97	97.55	46.78	71.47	100.28	111.57	89.03	117.22	115.00	108.05	99.93	98.43
	105.98	105.03	81.85	92.29	96.16	122.98	108.33	111.78	120.56	141.68	127.01	104.64
	15.39	13.35	17.92	11.19	13.21	22.75	28.46	33.55	32.25	26.48	31.52	27.10
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	21.05	21.18	21.43	21.74	22.28	21.09	23.43	22.66	22.97	23.22	23.55	22.45
	21.71	22.14	23.51	20.61	20.26	21.31	17.77	15.59	15.73	15.87	17.14	17.42
	15.37	15.15	15.16	15.79	16.47	16.10	16.48	16.30	16.32	26.12	26.22	24.58
	34.15	29.68	22.94	22.00	25.68	31.99	—	—	—	—	—	33.94
	-30.01	-7.48	-35.07	-20.82	4.12	-11.41	-19.30	5.44	-5.56	-33.63	-27.08	-6.21
	-1.69	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	-3.05
	-31.70	-7.48	-35.07	-20.82	4.12	-11.41	-19.30	5.44	-5.56	-33.63	-27.08	-9.26
	-7.79	3.14	-11.94	-7.22	1.45	-4.04	6.02	8.81	2.09	2.51	8.90	3.48
	-23.91	-4.34	-23.13	-13.60	2.67	-7.37	-13.28	14.25	-3.47	-31.12	-18.18	-5.78
	-1.52	-0.28	-1.47	-0.87	0.17	-0.47	-0.85	0.91	-0.22	-1.98	-1.16	-0.37
Key metrics
	5.38	29.81	3.60	15.58	40.85	26.00	14.95	37.33	26.49	8.36	16.28	32.74
	9.40%	43.40%	9.10%	25.80%	65.00%	24.50%	15.40%	40.00%	25.60%	7.50%	18.80%	54.80%
	-41.90%	-6.30%	-58.30%	-22.60%	4.20%	-6.90%	-13.70%	15.30%	-3.40%	-28.00%	-20.90%	-9.70%
	—	0.30%	—	0.00%	—	0.20%	—	—	—	—	—	—
	-9.20%	-35.20%	-59.10%	-35.40%	-39.20%	-4.60%	11.80%	56.20%	—	—	—	—
	-995.50%	41.10%	-74.20%	-195.40%	176.90%	76.30%	27.00%	346.50%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	225.78	231.56	399.84	327.35	402.55	302.79
	65.99	84.52	32.98	63.05	52.16	65.71
	291.77	316.08	432.82	390.40	454.71	368.50
	385.15	375.33	463.65	490.35	548.91	445.90
	57.85	55.67	117.01	107.70	163.35	104.60
	0.00	0.00	0.00	—	—	2.51
	85.40	86.63	90.15	91.54	86.13	80.54
	87.97	86.52	70.40	68.19	57.92	37.23
	61.47	62.57	65.20	101.61	96.20	140.07
	108.77	100.30	106.89	—	—	88.65
	-93.38	-59.25	-30.83	-99.95	-94.20	-77.40
	-1.69	0.00	0.00	-3.05	-2.00	-5.91
	-95.07	-59.25	-30.83	-103.00	-96.20	-83.31
	-23.81	20.85	20.96	26.59	37.33	52.84
	-64.98	-38.40	-9.87	-76.41	-58.87	-31.55
	-4.14	-2.45	-0.63	-4.87	-3.75	-2.01
Key metrics
	54.37	89.84	104.77	66.80	57.92	93.99
	24.08%	38.80%	26.20%	20.40%	14.40%	31.00%
	-28.78%	-16.60%	-2.50%	-23.30%	-14.60%	-10.40%
	—	0.60%	0.90%	—	—	—
	-37.16%	-42.10%	22.10%	-18.70%	32.90%	—
	—	-289.10%	87.10%	-29.80%	-86.60%	—
	—	19.12	0.91	—	—	—
	—	-1.20	-5.65	—	—	—
	—	0.16	0.17	—	—	—
	—	614.69	610.83	—	—	—
	—	394.7	216.4	—	—	—
Balance sheet
	—	5,126	5,122	—	—	—
	—	689.70	674.98	—	—	—
	—	15.93	67.73	—	—	—
	—	170.62	174.75	—	—	—
	—	155.12	134.25	—	—	—
	—	26.31	19.79	—	—	—
	—	781.98	798.17	—	—	—
	—	75.29	71.99	—	—	—
	—	868.90	652.10	—	—	—
	—	630.62	678.56	—	—	—
	—	506.76	430.87	—	—	—
	—	123.86	247.69	—	—	—
	—	3,882	4,030	—	—	—
Cash flow
	—	46.11	55.81	—	—	—
	—	21.68	-79.64	—	—	—
	—	-119.59	87.51	—	—	—
	—	26.99	54.90	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: -16.83%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -37.16%
Profit YoY (TTM): -1,642.09%

Consolidated

Sales CAGR 3Y: +6.71%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +0.20%
Profit YoY (TTM): -84.49%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 59.32%

Quarter	September 2026	June 2026
Promoter %	59.32%	59.32%

Holder	Type	Holding	Previous	Change
Adimans Technologies LLP	Promoter	59.32%	59.32%	0.00%
Mukul Mahavir Agrawal	Public	5.50%	5.50%	0.00%
Massachusetts Institute Of Technology	Public	2.28%	2.28%	0.00%
Hbm Healthcare Investments (Cayman) Ltd	Public	2.19%	2.19%	0.00%
Hsbc Mutual Fund - Hsbc Flexi Cap Fund	Public	1.41%	1.41%	0.00%
Tejas Trivedi	Public	1.00%	—	—
Janmejay Vyas Family Trust (Janmejay R. Vyas - Trustee)	Promoter Group	0.00%	0.00%	0.00%
B R Laboratories Limited	Promoter Group	0.00%	0.00%	0.00%
Creciente Direct Private Limited	Promoter Group	0.00%	0.00%	0.00%
Azafran Innovacion Ltd	Promoter Group	0.00%	0.00%	0.00%
Zenon Therapeutics AG	Promoter Group	0.00%	0.00%	0.00%
Ms. Aamanya Arpit Vyas	Promoter Group	0.00%	0.00%	0.00%
RTV Technochem Private Limited	Promoter Group	0.00%	0.00%	0.00%
Dishman Infrastructure Ltd	Promoter Group	0.00%	0.00%	0.00%
Kaustubh Farm Foundation	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Dishman Carbogen Amcis Limited	2,422	154.50	158.63	2.90%	+0.20% TTM	-84.49% TTM	-48.01%

Filings & corporate actions

Recent announcements

Pls. find enclosed herewith intimation of Conference Call to be held on 16th November 2026.4 Nov 2026 · Company Update / Analyst / Investor Meet
Pls. find enclosed herewith intimation under Regulations 30 and 30A of SEBI (LODR) Regulations, 2026.30 Oct 2026 · Others
Pls. find enclosed herewith intimation under Regulation 30A of SEBI (LODR) Regulations, 2015.29 Oct 2026 · Others
Pls. find enclosed herewith intimation of allotment of 3800 NCDs.15 Oct 2026 · Company Update / Allotment of Equity Shares
Please find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2026.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Wednesday, October 7, 2026 which was commenced at 13:30 p.m. and concluded at ....7 Oct 2026 · Board Meeting / Outcome of Board Meeting
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve a) the proposal of fund ....2 Oct 2026 · Board Meeting / Board Meeting
Pls. find enclosed herewith Voting Result of 19th AGM held on 30.09.2026.1 Oct 2026 · AGM/EGM / AGM
Please find attached herewith Proceedings of 19th AGM held on Wednesday, 30th September, 2026.30 Sep 2026 · AGM/EGM / AGM
Please find enclosed herewith Scrutinizer''s Report.30 Sep 2026 · AGM/EGM / AGM
Please find attached herewith Intimation of allotment of NCDs.28 Sep 2026 · Company Update / Allotment of Equity Shares
Pls. find enclosed herewith the intimation of closure of trading window for the quarter ending 30th September, 2026.24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pls. find enclosed herewith Disclosure regarding completion of US FDA Inspection at Company''s wholly owned subsidiary company site without any observation.12 Sep 2026 · Company Update / General
Please find attached herewith Newspaper Advertisement for AGM and E-Voting Instructions.7 Sep 2026 · AGM/EGM / AGM
Please find attached herewith Notice for the 19th AGM alongwith Annual Report.5 Sep 2026 · AGM/EGM / AGM
Please find attached herewith BRSR for the FY 2025-26.5 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
With reference to the captioned subject, please find enclosed herewith the copy of Notice of 19th Annual General Meeting ('AGM') of the Company scheduled to be held on Wednesday, the 30th ....5 Sep 2026 · Others / Reg. 34 (1) Annual Report
Please find attached herewith Newspaper Advertisement for an intimation regarding the 19th AGM to be held through VC or OAVM.2 Sep 2026 · AGM/EGM / AGM
Please find attached herewith an Intimation regarding date of AGM to be held on 30/09/2026.31 Aug 2026 · AGM/EGM / AGM
Pls. find enclosed herewith the disclosure of change in senior personnel of the Company.29 Aug 2026 · Company Update / Change in Management
Please find enclosed herewith transcript of conference call held on 17th August, 2026.21 Aug 2026 · Company Update / Earnings Call Transcript
The audio recording of Conference call arranged by the Company with investors on Monday, 17th August, 2026 which was commenced at 17:00 hrs (IST) to discuss the financial result and performance ....17 Aug 2026 · Company Update / Analyst / Investor Meet
Please find enclosed herewith Intimation of allotment of NCDs.17 Aug 2026 · Company Update / Allotment of Equity Shares
Pls. find enclosed herewith Investor Presentation.17 Aug 2026 · Company Update / Investor Presentation
Please find attached UFR for the quarter ended 30/06/2026.14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Please find attached UFR for the quarter ended on 30/06/2026.14 Aug 2026 · Result / Financial Results
The Company has arranged Conference Call with Investors on Monday, 17th August, 2026 at 17:00 hrs. (IST) to discuss the financial result and performance of the Company for the first quarter ....12 Aug 2026 · Company Update / Analyst / Investor Meet
The Company has arranged Conference Call with Investors on Monday, 17th August, 2026 at 17:00 hrs. (IST) to discuss the financial result and performance of the Company for the first quarter ....12 Aug 2026 · Company Update / Analyst / Investor Meet
We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Wednesday, August 12, 2026 which was commenced at 10:30 a.m. and concluded at ....12 Aug 2026 · Board Meeting / Outcome of Board Meeting
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the un-audited financial ....10 Aug 2026 · Board Meeting / Board Meeting
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Proposal Of Fund ....7 Aug 2026 · Board Meeting / Board Meeting
Pls. find enclosed herewith Newspaper Advertisement published on 17th July, 2026.17 Jul 2026 · Company Update / Newspaper Publication
Please find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026.14 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith Press Release.29 Jun 2026 · Company Update / Press Release / Media Release
Please find attached herewith Intimation of Closure of Trading Window.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Pls. find enclosed herewith Voting Result of EGM as per Regulation 44 of SEBI LODR.20 Jun 2026 · AGM/EGM / EGM
Please find attached herewith Scrutinizer''s Report of EGM held on Friday, 19th June, 2026.19 Jun 2026 · AGM/EGM / EGM
Please find attached herewith Proceedings of EGM held on today i.e. Friday, 19th June, 2026 through Video Conferencing.19 Jun 2026 · AGM/EGM / EGM
Pls. find enclosed herewith intimation of allotment of NCD.9 Jun 2026 · Company Update / Allotment of Equity Shares
Please find attached herewith Annual Secretarial Compliance Report for the year ended 31st March, 2026, issued by M/s. Ashok P. Pathak & Co., Company Secretaries.30 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance

Board meetings

14 Aug 2026 Board Meeting - Financial Results